GERN·Nasdaq·US
Geron
Geron is a commercial-stage biopharmaceutical company focused on hematology and blood cancer care. Its revenue is driven primarily by sales of RYTELO (imetelstat), an approved therapy for lower-risk myelodysplastic syndromes with transfusion-dependent anemia.
Thematic Position
Relationship Groups
Relationship details are part of the Pro plan.